BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21366534)

  • 21. Targeting the histidine pathway in Mycobacterium tuberculosis.
    Lunardi J; Nunes JE; Bizarro CV; Basso LA; Santos DS; Machado P
    Curr Top Med Chem; 2013; 13(22):2866-84. PubMed ID: 24111909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways of pyrimidine salvage in Pseudomonas and former Pseudomonas: detection of recycling enzymes using high-performance liquid chromatography.
    Beck DA; O'Donovan GA
    Curr Microbiol; 2008 Feb; 56(2):162-7. PubMed ID: 17962997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional analyses of Mycobacterium tuberculosis Rv3315c-encoded metal-dependent homotetrameric cytidine deaminase.
    Sánchez-Quitian ZA; Schneider CZ; Ducati RG; de Azevedo WF; Bloch C; Basso LA; Santos DS
    J Struct Biol; 2010 Mar; 169(3):413-23. PubMed ID: 20035876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic mechanism determination and analysis of metal requirement of dehydroquinate synthase from Mycobacterium tuberculosis H37Rv: an essential step in the function-based rational design of anti-TB drugs.
    de Mendonça JD; Adachi O; Rosado LA; Ducati RG; Santos DS; Basso LA
    Mol Biosyst; 2011 Jan; 7(1):119-28. PubMed ID: 20978656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of mapping the spontaneous mutations with 5-flurouracil in uracil phosphoribosyltransferase from Mycobacterium tuberculosis.
    Ghode P; Jobichen C; Ramachandran S; Bifani P; Sivaraman J
    Biochem Biophys Res Commun; 2015 Nov; 467(3):577-82. PubMed ID: 26456658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAHP synthase from Mycobacterium tuberculosis H37Rv: cloning, expression, and purification of functional enzyme.
    Rizzi C; Frazzon J; Ely F; Weber PG; da Fonseca IO; Gallas M; Oliveira JS; Mendes MA; de Souza BM; Palma MS; Santos DS; Basso LA
    Protein Expr Purif; 2005 Mar; 40(1):23-30. PubMed ID: 15721768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrimidine salvage in Giardia lamblia.
    Aldritt SM; Tien P; Wang CC
    J Exp Med; 1985 Mar; 161(3):437-45. PubMed ID: 3973534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Housecleaning of pyrimidine nucleotide pool coordinates metabolic adaptation of nongrowing Mycobacterium tuberculosis.
    Shi KX; Wu YK; Tang BK; Zhao GP; Lyu LD
    Emerg Microbes Infect; 2019; 8(1):40-44. PubMed ID: 30866758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional shikimate dehydrogenase from Mycobacterium tuberculosis H37Rv: purification and characterization.
    Fonseca IO; Magalhães ML; Oliveira JS; Silva RG; Mendes MA; Palma MS; Santos DS; Basso LA
    Protein Expr Purif; 2006 Apr; 46(2):429-37. PubMed ID: 16298142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrimidine metabolism in Tritrichomonas foetus.
    Wang CC; Verham R; Tzeng SF; Aldritt S; Cheng HW
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2564-8. PubMed ID: 6573672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.
    Murphy DJ; Brown JR
    BMC Infect Dis; 2007 Jul; 7():84. PubMed ID: 17655757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining molecular dynamics and docking simulations of the cytidine deaminase from Mycobacterium tuberculosis H37Rv.
    Timmers LF; Ducati RG; Sánchez-Quitian ZA; Basso LA; Santos DS; de Azevedo WF
    J Mol Model; 2012 Feb; 18(2):467-79. PubMed ID: 21541749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathways of pyrimidine salvage in Streptomyces.
    Hughes LE; Beck DA; O'Donovan GA
    Curr Microbiol; 2005 Jan; 50(1):8-10. PubMed ID: 15696258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleoside analogs and tuberculosis: new weapons against an old enemy.
    Ferrari V; Serpi M
    Future Med Chem; 2015; 7(3):291-314. PubMed ID: 25826361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purine metabolism in Mycobacterium tuberculosis as a target for drug development.
    Parker WB; Long MC
    Curr Pharm Des; 2007; 13(6):599-608. PubMed ID: 17346177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The resumption of consumption -- a review on tuberculosis.
    Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo pyrimidine biosynthesis in the oomycete plant pathogen Phytophthora infestans.
    García-Bayona L; Garavito MF; Lozano GL; Vasquez JJ; Myers K; Fry WE; Bernal A; Zimmermann BH; Restrepo S
    Gene; 2014 Mar; 537(2):312-21. PubMed ID: 24361203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrimidine nucleotide synthesis in rat embryo cells infected with X14 or H-1 parvovirus.
    Ricceri G; Ragusa N; Avola R; Barcellona ML; Castro A
    Acta Virol; 1978 Mar; 22(2):104-12. PubMed ID: 26195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.